Ben Tre Pharmaceutical JSC (STC:DBT) EV-to-EBIT: (As of Jul. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STC:DBT Ben Tre Pharmaceutical JSC STC:DBT
13 GF Score
Price ₫12,500.00
! 1 Warning Sign
View Full Analysis

What is Ben Tre Pharmaceutical JSC EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Ben Tre Pharmaceutical JSC's Enterprise Value is ₫274,590.78 Mil. Ben Tre Pharmaceutical JSC does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Ben Tre Pharmaceutical JSC's EV-to-EBIT at this moment.

The historical rank and industry rank for Ben Tre Pharmaceutical JSC's EV-to-EBIT or its related term are showing as below:

STC:DBT's EV-to-EBIT is not ranked *
in the Drug Manufacturers industry.
Industry Median: 15.95
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Ben Tre Pharmaceutical JSC's Enterprise Value for the quarter that ended in . 20 was ₫0.00 Mil. Ben Tre Pharmaceutical JSC does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Ben Tre Pharmaceutical JSC's Earnings Yield (Joel Greenblatt) % at this moment.

Ben Tre Pharmaceutical JSC  (STC:DBT) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Ben Tre Pharmaceutical JSC's Earnings Yield (Joel Greenblatt) % for the quarter that ended in . 20 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: . 20 ) =EBIT / Enterprise Value (Q: . 20 )
=/
= %

Ben Tre Pharmaceutical JSC EV-to-EBIT Related Terms

Ben Tre Pharmaceutical JSC EV-to-EBIT Historical Data

* Premium members only.

The historical data trend for Ben Tre Pharmaceutical JSC's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ben Tre Pharmaceutical JSC EV-to-EBIT Chart

Ben Tre Pharmaceutical JSC Annual Data
Trend
EV-to-EBIT

Ben Tre Pharmaceutical JSC Semi-Annual Data
EV-to-EBIT

STC:DBT vs ZTS, UTHR, VTRS: EV-to-EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ben Tre Pharmaceutical JSC's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ben Tre Pharmaceutical JSC EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ben Tre Pharmaceutical JSC's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Ben Tre Pharmaceutical JSC's EV-to-EBIT falls into.


STC:DBT
13GF Score
Ben Tre Pharmaceutical JSC STC:DBT
EV-to-EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ben Tre Pharmaceutical JSC EV-to-EBIT Calculation

Ben Tre Pharmaceutical JSC's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=274590.775/
=

Ben Tre Pharmaceutical JSC Business Description

Address No. 6A3, National Highway 60, Phu Tan Ward, Vinh Long Province, Ben Tre, VNM
Ben Tre Pharmaceutical JSC is based in Vietnam. The company is engaged in trading in pharmaceuticals, functional foods, vaccines, cosmetics, medical equipment, & medical machinery. It is also engaged in the Import and export of testing chemicals & biological products, Manufacturing medicines for human treatment, producing pharmaceuticals, chemicals, and medicinal herbs, and Leasing warehouses and premises.
13GF Score

Get the complete analysis for STC:DBT

EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫12,500.00
Price